These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15196346)

  • 41. Quantitative sputum cell counts as a marker of airway inflammation in clinical practice.
    Hargreave FE
    Curr Opin Allergy Clin Immunol; 2007 Feb; 7(1):102-6. PubMed ID: 17218819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of exhaled nitric oxide in the management of asthma.
    Pavord ID; Shaw D
    J Asthma; 2008 Sep; 45(7):523-31. PubMed ID: 18773320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiating COPD from asthma in clinical practice.
    Mosenifar Z
    Postgrad Med; 2009 May; 121(3):105-12. PubMed ID: 19491547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asthma and COPD.
    Welte T; Groneberg DA
    Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():35-40. PubMed ID: 16580185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asthma biomarkers in sputum.
    Spahn JD
    Immunol Allergy Clin North Am; 2007 Nov; 27(4):607-22; vi. PubMed ID: 17996579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The art and science of paediatric 'asthma'.
    Everard ML
    Clin Exp Allergy; 2007 Nov; 37(11):1581-5. PubMed ID: 17949370
    [No Abstract]   [Full Text] [Related]  

  • 47. [What can be done for problematic asthma patients?].
    Arnheim K
    MMW Fortschr Med; 2005 May; 147(21):4-6. PubMed ID: 15966163
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk assessment in asthma and COPD: a potential role for biomarkers?
    Taylor DR
    Thorax; 2009 Mar; 64(3):261-4. PubMed ID: 19252021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MR for the evaluation of obstructive pulmonary disease.
    Ley-Zaporozhan J; Puderbach M; Kauczor HU
    Magn Reson Imaging Clin N Am; 2008 May; 16(2):291-308, ix. PubMed ID: 18474333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
    Berry MA; Shaw DE; Green RH; Brightling CE; Wardlaw AJ; Pavord ID
    Clin Exp Allergy; 2005 Sep; 35(9):1175-9. PubMed ID: 16164444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Difficulties in the interpretation of lung function tests in the diagnosis of asthma and chronic obstructive pulmonary disease.
    Raghunath AS; Innes A; Norfolk L; Hannant M; Greene T; Greenstone M; Morice AH
    J Asthma; 2006 Nov; 43(9):657-60. PubMed ID: 17092845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
    Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
    Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort.
    Martinez CH; Li SX; Hirzel AJ; Stolberg VR; Alexis NE; Barr RG; Bleecker ER; Carretta EE; Christenson SA; Cooper CB; Couper DJ; Doerschuk CM; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kaner RJ; Martinez FJ; Meyers DA; O'Neal WK; Paine R; Putcha N; Rennard SI; Woodruff PG; Zeidler M; Curtis JL; Freeman CM;
    J Allergy Clin Immunol; 2018 Jan; 141(1):429-432. PubMed ID: 28916185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Airway inflammation and cough sensitivity in cough-variant asthma.
    De Diego A; Martínez E; Perpiñá M; Nieto L; Compte L; Macián V; Senent L
    Allergy; 2005 Nov; 60(11):1407-11. PubMed ID: 16197473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease.
    Mauad T; Dolhnikoff M
    Curr Opin Pulm Med; 2008 Jan; 14(1):31-8. PubMed ID: 18043273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peak flow meters still useful but require consistency rather than accuracy.
    Connolly CK
    Thorax; 2004 Jan; 59(1):82; author reply 82-3. PubMed ID: 14694259
    [No Abstract]   [Full Text] [Related]  

  • 58. Stability of inflammatory phenotypes in asthma.
    Green RH; Pavord I
    Thorax; 2012 Aug; 67(8):665-7. PubMed ID: 22544895
    [No Abstract]   [Full Text] [Related]  

  • 59. Sputum induction in COPD--it's safe, so now what do we do?
    Sutherland ER
    COPD; 2006 Jun; 3(2):73-4. PubMed ID: 17175668
    [No Abstract]   [Full Text] [Related]  

  • 60. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation.
    Efthimiadis A; Spanevello A; Hamid Q; Kelly MM; Linden M; Louis R; Pizzichini MM; Pizzichini E; Ronchi C; Van Overvel F; Djukanović R
    Eur Respir J Suppl; 2002 Sep; 37():19s-23s. PubMed ID: 12361358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.